{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:58:37Z","timestamp":1787169517491,"version":"build-2736575974"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Military infectious disease program"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is an important human pathogen. In cell culture, CCHFV is sensed by the cytoplasmic RNA sensor retinoic acid-inducible gene I (RIG-I) molecule and its adaptor molecule mitochondrial antiviral signaling (MAVS) protein. MAVS initiates both type I interferon (IFN-I) and proinflammatory responses. Here, we studied the role MAVS plays in CCHFV infection in mice in both the presence and absence of IFN-I activity. MAVS-deficient mice were not susceptible to CCHFV infection when IFN-I signaling was active and showed no signs of disease. When IFN-I signaling was blocked by antibody, MAVS-deficient mice lost significant weight, but were uniformly protected from lethal disease, whereas all control mice succumbed to infection. Cytokine activity in the infected MAVS-deficient mice was markedly blunted. Subsequent investigation revealed that CCHFV infected mice lacking TNF-\u03b1 receptor signaling (TNFA-R-deficient), but not IL-6 or IL-1 activity, had more limited liver injury and were largely protected from lethal outcomes. Treatment of mice with an anti-TNF-\u03b1 neutralizing antibody also conferred partial protection in a post-virus exposure setting. Additionally, we found that a disease causing, but non-lethal strain of CCHFV produced more blunted inflammatory cytokine responses compared to a lethal strain in mice. Our work reveals that MAVS activation and cytokine production both contribute to CCHFV pathogenesis, potentially identifying new therapeutic targets to treat this disease.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010485","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T13:24:42Z","timestamp":1652966682000},"page":"e1010485","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-313X","authenticated-orcid":true,"given":"Joseph W.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis R.","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon P.","family":"Daye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace D.","family":"Blancett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin J.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura R.","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"issue":"4","key":"ppat.1010485.ref001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","article-title":"The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa","volume":"15","author":"H. Hoogstraal","year":"1979","journal-title":"J Med Entomol"},{"issue":"3","key":"ppat.1010485.ref002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"CA Whitehouse","year":"2004","journal-title":"Antiviral research"},{"issue":"4","key":"ppat.1010485.ref003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"O. Ergonul","year":"2006","journal-title":"The Lancet infectious diseases"},{"issue":"1","key":"ppat.1010485.ref004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"DA Bente","year":"2013","journal-title":"Antiviral research"},{"issue":"6","key":"ppat.1010485.ref005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","article-title":"Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited","volume":"12","author":"O Ergonul","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"ppat.1010485.ref006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa1615162","article-title":"Autochthonous Crimean-Congo Hemorrhagic Fever in Spain","volume":"377","author":"A Negredo","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"ppat.1010485.ref007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3201\/eid2101.141413","article-title":"Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009","volume":"21","author":"NG Conger","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 4","key":"ppat.1010485.ref008","doi-asserted-by":"crossref","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","article-title":"The clinical pathology of Crimean-Congo hemorrhagic fever","volume":"11","author":"R Swanepoel","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"8","key":"ppat.1010485.ref009","first-page":"839","article-title":"Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis","volume":"121","author":"FJ Burt","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"ppat.1010485.ref010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268898001344","article-title":"Experimental infection of ostriches with Crimean-Congo haemorrhagic fever virus","volume":"121","author":"R Swanepoel","year":"1998","journal-title":"Epidemiol Infect"},{"issue":"5","key":"ppat.1010485.ref011","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4269\/ajtmh.1980.29.941","article-title":"Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976","volume":"29","author":"MI Burney","year":"1980","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ppat.1010485.ref012","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/422000","article-title":"Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy","volume":"39","author":"O Ergonul","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12\u201313","key":"ppat.1010485.ref013","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.micinf.2010.07.012","article-title":"Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever","volume":"12","author":"A Engin","year":"2010","journal-title":"Microbes Infect"},{"issue":"10","key":"ppat.1010485.ref014","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/jmv.24519","article-title":"Is there any relationship between Toll-like receptor 3 c.1377C\/T and -7C\/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever?","volume":"88","author":"A Engin","year":"2016","journal-title":"J Med Virol"},{"issue":"7","key":"ppat.1010485.ref015","doi-asserted-by":"crossref","DOI":"10.3390\/v11070590","article-title":"Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease","volume":"11","author":"AR Garrison","year":"2019","journal-title":"Viruses"},{"issue":"21","key":"ppat.1010485.ref016","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"DA Bente","year":"2010","journal-title":"J Virol"},{"issue":"Pt 6","key":"ppat.1010485.ref017","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"S Bereczky","year":"2010","journal-title":"J Gen Virol"},{"issue":"12","key":"ppat.1010485.ref018","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/infdis\/jit061","article-title":"Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha\/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy","volume":"207","author":"M Zivcec","year":"2013","journal-title":"J Infect Dis"},{"key":"ppat.1010485.ref019","article-title":"Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice","author":"ME Lindquist","year":"2018","journal-title":"J Virol"},{"issue":"9","key":"ppat.1010485.ref020","doi-asserted-by":"crossref","first-page":"e0005908","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"AR Garrison","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ppat.1010485.ref021","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/zph.12469","article-title":"Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures","volume":"65","author":"EJ Mendoza","year":"2018","journal-title":"Zoonoses Public Health"},{"issue":"1","key":"ppat.1010485.ref022","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1038\/s41598-020-69054-3","article-title":"Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis","volume":"10","author":"C Ranadheera","year":"2020","journal-title":"Sci Rep"},{"issue":"20","key":"ppat.1010485.ref023","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.1128\/JVI.01643-15","article-title":"RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus","volume":"89","author":"JR Spengler","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"ppat.1010485.ref024","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2006.04.007","article-title":"Cytokine levels in Crimean-Congo hemorrhagic fever","volume":"36","author":"A Papa","year":"2006","journal-title":"J Clin Virol"},{"issue":"7","key":"ppat.1010485.ref025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/500836","article-title":"Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever","volume":"193","author":"O Ergonul","year":"2006","journal-title":"J Infect Dis"},{"issue":"7","key":"ppat.1010485.ref026","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/CVI.00530-09","article-title":"Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever","volume":"17","author":"A Saksida","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ppat.1010485.ref027","doi-asserted-by":"crossref","first-page":"105244","DOI":"10.1016\/j.antiviral.2022.105244","article-title":"Immunobiology of Crimean-Congo hemorrhagic fever","author":"SE Rodriguez","year":"2022","journal-title":"Antiviral research"},{"issue":"7","key":"ppat.1010485.ref028","doi-asserted-by":"crossref","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection","volume":"5","author":"JW Golden","year":"2019","journal-title":"Sci Adv"},{"issue":"3","key":"ppat.1010485.ref029","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.celrep.2016.12.069","article-title":"A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection","volume":"18","author":"M Dutta","year":"2017","journal-title":"Cell Rep"},{"issue":"11","key":"ppat.1010485.ref030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jir.2006.26.804","article-title":"Blocking monoclonal antibodies specific for mouse IFN-alpha\/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection","volume":"26","author":"KC Sheehan","year":"2006","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"ppat.1010485.ref031","doi-asserted-by":"crossref","first-page":"e0005296","DOI":"10.1371\/journal.pntd.0005296","article-title":"Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon","volume":"11","author":"DR Smith","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"issue":"5","key":"ppat.1010485.ref032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"RB Seth","year":"2005","journal-title":"Cell"},{"issue":"5","key":"ppat.1010485.ref033","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2006.04.004","article-title":"The specific and essential role of MAVS in antiviral innate immune responses","volume":"24","author":"Q Sun","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"ppat.1010485.ref034","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4269\/ajtmh.1987.36.120","article-title":"Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa","volume":"36","author":"R Swanepoel","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"18","key":"ppat.1010485.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00554-19","article-title":"Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence","volume":"93","author":"DW Hawman","year":"2019","journal-title":"J Virol"},{"issue":"6","key":"ppat.1010485.ref036","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.1820704116","article-title":"Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice","volume":"116","author":"A Wang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ppat.1010485.ref037","doi-asserted-by":"crossref","first-page":"e0218928","DOI":"10.1371\/journal.pone.0218928","article-title":"Dendritic cell-associated MAVS is required to control West Nile virus replication and ensuing humoral immune responses","volume":"14","author":"K Roe","year":"2019","journal-title":"PLoS One"},{"issue":"6307","key":"ppat.1010485.ref038","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.aaf8325","article-title":"MAVS-dependent host species range and pathogenicity of human hepatitis A virus","volume":"353","author":"A Hirai-Yuki","year":"2016","journal-title":"Science"},{"issue":"12","key":"ppat.1010485.ref039","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1086\/657416","article-title":"A paradoxical role for neutrophils in the pathogenesis of West Nile virus","volume":"202","author":"F Bai","year":"2010","journal-title":"J Infect Dis"},{"issue":"Pt 1","key":"ppat.1010485.ref040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1099\/vir.0.015701-0","article-title":"Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells","volume":"91","author":"CN Peyrefitte","year":"2010","journal-title":"J Gen Virol"},{"issue":"2","key":"ppat.1010485.ref041","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","article-title":"The pathogenesis of Rift Valley fever virus in the mouse model","volume":"407","author":"DR Smith","year":"2010","journal-title":"Virology"},{"issue":"11","key":"ppat.1010485.ref042","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/cdd.2015.35","article-title":"TRAF2 is a biologically important necroptosis suppressor","volume":"22","author":"SL Petersen","year":"2015","journal-title":"Cell Death Differ"},{"issue":"Pt 13","key":"ppat.1010485.ref043","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1242\/jcs.115.13.2757","article-title":"Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8","volume":"115","author":"M Fotin-Mleczek","year":"2002","journal-title":"J Cell Sci"},{"issue":"3","key":"ppat.1010485.ref044","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"C Brenner","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"ppat.1010485.ref045","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"RF Schwabe","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"ppat.1010485.ref046","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"RF Schwabe","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"ppat.1010485.ref047","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/gast.2000.9364","article-title":"Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure","volume":"119","author":"K Streetz","year":"2000","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"ppat.1010485.ref048","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-015-0344-y","article-title":"Anti-TNF in rheumatoid arthritis: an overview","volume":"165","author":"H Radner","year":"2015","journal-title":"Wien Med Wochenschr"},{"key":"ppat.1010485.ref049","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fcell.2019.00108","article-title":"Sepsis: Inflammation Is a Necessary Evil","volume":"7","author":"C Nedeva","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"ppat.1010485.ref050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-9-90","article-title":"The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey","volume":"9","author":"K Midilli","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ppat.1010485.ref051","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7883\/yoken.JJID.2015.533","article-title":"The First Fatal Case of Crimean-Congo Hemorrhagic Fever Caused by the AP92-Like Strain of the Crimean-Congo Hemorrhagic Fever Virus","volume":"69","author":"M Salehi-Vaziri","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"ppat.1010485.ref052","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-422X-5-7","article-title":"The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo","volume":"5","author":"D Duh","year":"2008","journal-title":"Virology journal"},{"key":"ppat.1010485.ref053","article-title":"A cynomolgus macaque model for Crimean-Congo haemorrhagic fever","author":"E Haddock","year":"2018","journal-title":"Nat Microbiol"},{"issue":"9","key":"ppat.1010485.ref054","doi-asserted-by":"crossref","first-page":"e1008050","DOI":"10.1371\/journal.ppat.1008050","article-title":"Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis","volume":"15","author":"DR Smith","year":"2019","journal-title":"PLoS Pathog"},{"issue":"17","key":"ppat.1010485.ref055","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.febslet.2014.05.046","article-title":"Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis","volume":"588","author":"U Neniskyte","year":"2014","journal-title":"FEBS Lett"},{"key":"ppat.1010485.ref056","doi-asserted-by":"crossref","first-page":"104703","DOI":"10.1016\/j.antiviral.2019.104703","article-title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination","volume":"174","author":"EC Clarke","year":"2020","journal-title":"Antiviral research"},{"issue":"2","key":"ppat.1010485.ref057","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","article-title":"Constitutive type I interferon modulates homeostatic balance through tonic signaling","volume":"36","author":"DJ Gough","year":"2012","journal-title":"Immunity"},{"issue":"9","key":"ppat.1010485.ref058","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.4049\/jimmunol.170.9.4776","article-title":"IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis","volume":"170","author":"I Teige","year":"2003","journal-title":"J Immunol"},{"issue":"6515","key":"ppat.1010485.ref059","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"P Bastard","year":"2020","journal-title":"Science"},{"issue":"23","key":"ppat.1010485.ref060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in Inflammatory Disease","volume":"20","author":"S Kany","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"ppat.1010485.ref061","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40259-017-0231-8","article-title":"Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review","volume":"31","author":"V Strand","year":"2017","journal-title":"BioDrugs"},{"issue":"2","key":"ppat.1010485.ref062","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"VV Sarathy","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"ppat.1010485.ref063","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(21)00035-7","article-title":"The right place for IL-1 inhibition in COVID-19","volume":"9","author":"G Cavalli","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"16","key":"ppat.1010485.ref064","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 Receptor Inhibition in Covid-19\u2014Cooling the Inflammatory Soup","volume":"384","author":"EJ Rubin","year":"2021","journal-title":"N Engl J Med"},{"key":"ppat.1010485.ref065","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"NR Council","year":"2011","edition":"8"},{"issue":"1","key":"ppat.1010485.ref066","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2010.09.018","article-title":"Complete sequence and phylogenetic characterisation of Crimean-Congo hemorrhagic fever virus from Afghanistan","volume":"50","author":"S Olschlager","year":"2011","journal-title":"J Clin Virol"},{"issue":"1","key":"ppat.1010485.ref067","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4269\/ajtmh.17-0165","article-title":"Sequence Optimized Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of Crimean-Congo Hemorrhagic Fever Virus","volume":"98","author":"JW Koehler","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"ppat.1010485.ref068","volume-title":"Laboratory methods for histotechnology","author":"EB Prophet","year":"1992"},{"issue":"2","key":"ppat.1010485.ref069","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","article-title":"The pathogenesis of Rift Valley fever virus in the mouse model","volume":"407","author":"DR Smith","year":"2010","journal-title":"Virology"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T13:25:47Z","timestamp":1652966747000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010485"}},"subtitle":[],"editor":[{"given":"Christina F.","family":"Spiropoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010485","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}